Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Piero Ruscitti and Roberto Giacomelli.
Piero Ruscitti
Connection Strength
19.883
Roberto Giacomelli
  1. Response to: 'Correspondence on 'Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences' by Ruscitti et al' by Chen et al. Ann Rheum Dis. 2020 Sep 09.
    View in: PubMed
    Score: 0.902
  2. Ferritin and Severe COVID-19, from Clinical Observations to Pathogenic Implications and Therapeutic Perspectives. Isr Med Assoc J. 2020 Aug; 22(8):516-518.
    View in: PubMed
    Score: 0.895
  3. Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences. Ann Rheum Dis. 2020 09; 79(9):1152-1155.
    View in: PubMed
    Score: 0.893
  4. Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm. Front Immunol. 2020; 11:1130.
    View in: PubMed
    Score: 0.884
  5. Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? Ann Rheum Dis. 2020 11; 79(11):1515-1516.
    View in: PubMed
    Score: 0.883
  6. Cytokine storm syndrome in severe COVID-19. Autoimmun Rev. 2020 07; 19(7):102562.
    View in: PubMed
    Score: 0.880
  7. Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study. Medicine (Baltimore). 2019 Apr; 98(15):e15123.
    View in: PubMed
    Score: 0.816
  8. IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study. Medicine (Baltimore). 2019 Feb; 98(7):e14587.
    View in: PubMed
    Score: 0.807
  9. Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities. J Immunol Res. 2018; 2018:8410182.
    View in: PubMed
    Score: 0.796
  10. Pathogenesis of adult onset still's disease: current understanding and new insights. Expert Rev Clin Immunol. 2018 11; 14(11):965-976.
    View in: PubMed
    Score: 0.790
  11. Dose adjustments and discontinuation in TNF inhibitors treated patients: when and how. A systematic review of literature. Rheumatology (Oxford). 2018 10 01; 57(57 Suppl 7):vii23-vii31.
    View in: PubMed
    Score: 0.788
  12. The Emerging Role of IL-1 Inhibition in Patients Affected by Rheumatoid Arthritis and Diabetes. Rev Recent Clin Trials. 2018; 13(3):210-214.
    View in: PubMed
    Score: 0.749
  13. Biologic drugs in adult onset Still's disease: a systematic review and meta-analysis of observational studies. Expert Rev Clin Immunol. 2017 11; 13(11):1089-1097.
    View in: PubMed
    Score: 0.734
  14. Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients. Clin Rheumatol. 2017 Dec; 36(12):2839-2845.
    View in: PubMed
    Score: 0.733
  15. Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? Expert Rev Clin Immunol. 2017 11; 13(11):1041-1047.
    View in: PubMed
    Score: 0.731
  16. Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study. Medicine (Baltimore). 2017 Aug; 96(34):e7896.
    View in: PubMed
    Score: 0.727
  17. Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study. PLoS One. 2017; 12(7):e0181203.
    View in: PubMed
    Score: 0.724
  18. Increased Cardiovascular Events and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients: 1 Year Prospective Single Centre Study. PLoS One. 2017; 12(1):e0170108.
    View in: PubMed
    Score: 0.701
  19. Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers. Autoimmun Rev. 2017 Jan; 16(1):16-21.
    View in: PubMed
    Score: 0.685
  20. Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders. Adv Rheumatol. 2021 07 08; 61(1):45.
    View in: PubMed
    Score: 0.239
  21. Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis. Clin Exp Rheumatol. 2020 Nov-Dec; 38(6):1247-1254.
    View in: PubMed
    Score: 0.229
  22. The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection. Expert Rev Clin Immunol. 2020 12; 16(12):1205-1215.
    View in: PubMed
    Score: 0.229
  23. Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases. Autoimmun Rev. 2019 Oct; 18(10):102369.
    View in: PubMed
    Score: 0.209
  24. The Vessels Contribute to Fibrosis in Systemic Sclerosis. Isr Med Assoc J. 2019 Jul; 21(7):471-474.
    View in: PubMed
    Score: 0.208
  25. Adipose stromal vascular fraction and regenerative therapy in SSc: response to the article by Magalon et al. Ann Rheum Dis. 2020 05; 79(5):e53.
    View in: PubMed
    Score: 0.202
  26. Laboratory Assessment of Patients with Suspected Rheumatic Musculoskeletal Diseases: Challenges and Pitfalls. Curr Rheumatol Rev. 2019; 15(1):27-43.
    View in: PubMed
    Score: 0.201
  27. Cardiovascular and Metabolic Comorbidities in Rheumatoid Arthritis. Curr Rheumatol Rep. 2018 11 05; 20(12):81.
    View in: PubMed
    Score: 0.198
  28. Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis. Autoimmun Rev. 2019 Jan; 18(1):93-106.
    View in: PubMed
    Score: 0.198
  29. Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy. Arthritis Res Ther. 2018 10 03; 20(1):223.
    View in: PubMed
    Score: 0.197
  30. A comprehensive review on adult onset Still's disease. J Autoimmun. 2018 09; 93:24-36.
    View in: PubMed
    Score: 0.195
  31. Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort. J Rheumatol. 2018 06; 45(6):864-872.
    View in: PubMed
    Score: 0.191
  32. The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis. Mod Rheumatol. 2018 Nov; 28(6):922-932.
    View in: PubMed
    Score: 0.189
  33. Cardiovascular Disease in Primary Sjögren's Syndrome. Rev Recent Clin Trials. 2018; 13(3):164-169.
    View in: PubMed
    Score: 0.187
  34. Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study. Medicine (Baltimore). 2017 Oct; 96(42):e8180.
    View in: PubMed
    Score: 0.184
  35. International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. Autoimmun Rev. 2017 Sep; 16(9):911-924.
    View in: PubMed
    Score: 0.181
  36. What could we learn from the sub-analysis of a single nation cohort in a worldwide study? Lessons from the results observed in the Italian cohort of the GO-MORE trial. Clin Exp Rheumatol. 2017 Jul-Aug; 35(4):623-629.
    View in: PubMed
    Score: 0.180
  37. Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies very early cardiac involvement in systemic sclerosis patients of recent onset. Int J Rheum Dis. 2017 Sep; 20(9):1247-1260.
    View in: PubMed
    Score: 0.180
  38. Interstitial lung disease in systemic sclerosis: current and future treatment. Rheumatol Int. 2017 Jun; 37(6):853-863.
    View in: PubMed
    Score: 0.175
  39. Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey. RMD Open. 2021 08; 7(3).
    View in: PubMed
    Score: 0.060
  40. Isolated "puffy hands" following COVID-19: clue to a long-term capillary leakage syndrome? Clin Rheumatol. 2021 09; 40(9):3863-3864.
    View in: PubMed
    Score: 0.060
  41. Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: a report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group. Ann Rheum Dis. 2021 11; 80(11):1498-1501.
    View in: PubMed
    Score: 0.059
  42. Levels and Factors Associated with Resilience in Italian Healthcare Professionals during the COVID-19 Pandemic: A Web-Based Survey. Behav Sci (Basel). 2020 Nov 29; 10(12).
    View in: PubMed
    Score: 0.057
  43. Rheumatic manifestations of COVID-19: a systematic review and meta-analysis. BMC Rheumatol. 2020; 4:65.
    View in: PubMed
    Score: 0.057
  44. Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects? Autoimmun Rev. 2020 May; 19(5):102524.
    View in: PubMed
    Score: 0.055
  45. Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study. Rheumatol Int. 2020 Jun; 40(6):951-958.
    View in: PubMed
    Score: 0.053
  46. Vitamin D increases the production of IL-10 by regulatory T cells in patients with systemic sclerosis. Clin Exp Rheumatol. 2019 Jul-Aug; 37 Suppl 119(4):76-81.
    View in: PubMed
    Score: 0.053
  47. Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease. Front Pharmacol. 2019; 10:918.
    View in: PubMed
    Score: 0.052
  48. Low-Dose Aspirin as Primary Prophylaxis for Cardiovascular Events in Rheumatoid Arthritis: An Italian Multicentre Retrospective Study. Cardiol Res Pract. 2019; 2019:2748035.
    View in: PubMed
    Score: 0.051
  49. Long-Term Retention Rate of Anakinra in Adult Onset Still's Disease and Predictive Factors for Treatment Response. Front Pharmacol. 2019; 10:296.
    View in: PubMed
    Score: 0.051
  50. The effect of non-TNF-targeted biologics on vascular dysfunction in rheumatoid arthritis: A systematic literature review. Autoimmun Rev. 2019 May; 18(5):501-509.
    View in: PubMed
    Score: 0.051
  51. T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy. Clin Exp Rheumatol. 2019 Jan-Feb; 37 Suppl 116(1):81-89.
    View in: PubMed
    Score: 0.051
  52. Downregulation of miRNA17-92 cluster marks V?9Vd2 T cells from patients with rheumatoid arthritis. Arthritis Res Ther. 2018 Oct 22; 20(1):236.
    View in: PubMed
    Score: 0.049
  53. Interleukin-25 Axis Is Involved in the Pathogenesis of Human Primary and Experimental Murine Sjögren's Syndrome. Arthritis Rheumatol. 2018 08; 70(8):1265-1275.
    View in: PubMed
    Score: 0.048
  54. The effect of non-TNF-targeted biologics and small molecules on insulin resistance in inflammatory arthritis. Autoimmun Rev. 2018 Apr; 17(4):399-404.
    View in: PubMed
    Score: 0.047
  55. Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders. Autoimmun Rev. 2018 Apr; 17(4):366-375.
    View in: PubMed
    Score: 0.047
  56. Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study. Front Pharmacol. 2017; 8:369.
    View in: PubMed
    Score: 0.045
  57. Computed Tomography and MR Imaging in Rheumatoid Arthritis. Radiol Clin North Am. 2017 Sep; 55(5):997-1007.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.